Skip to main content

Combinational Therapy in Triple Negative Breast Cancer

  • 1st Edition - April 28, 2022
  • Author: Manzoor Ahmad Mir
  • Language: English
  • Paperback ISBN:
    9 7 8 - 0 - 3 2 3 - 9 6 1 3 6 - 3
  • eBook ISBN:
    9 7 8 - 0 - 3 2 3 - 9 6 1 3 7 - 0

Combinational Therapy in Triple Negative Breast Cancer discusses TNBC at the molecular level from a holistic approach, focusing on combinational strategies targeting various p… Read more

Combinational Therapy in Triple Negative Breast Cancer

Purchase options

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Book bundle cover eBook and print

Institutional subscription on ScienceDirect

Request a sales quote

Combinational Therapy in Triple Negative Breast Cancer discusses TNBC at the molecular level from a holistic approach, focusing on combinational strategies targeting various pathways involved in this specific cancer type. Using a monotherapy for the treatment of cancer, especially high-grade tumors like TNBC, is mostly worthless due to the inherent genetic instability of tumor cells to develop intrinsic and acquired resistance. Combination therapy presents more, or at least the same, effectiveness with lower doses of every single agent and decreases the likelihood of chemoresistance, making it essential to understand for multiple therapy options.

The book is a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of combinational therapies to treat triple negative breast cancer.